NCT05781906 - Human Mass Balance of [14C]HMPL-523 in Healthy Adult Male Chinese Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 8, 2023

Primary Completion Date

June 1, 2023

Study Completion Date

December 6, 2023

Conditions

Imumune Thrombocytopenia(ITP) Human Mass Balance

Interventions

DRUG

HMPL-523

D1-D7: HMPL-523 Tablet 300 mg QD

DRUG

150 µCi [14C]HMPL-523

D8: \[14C\] HMPL-523 Suspension 300 mg/150 μCi Single dose

Trial Locations (1)

The First Affiliated Hospital of Soochow University, Suzhou